SIBN Stock Summary and Trading Ideas (Si-Bone | NASDAQ:SIBN)

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Si-Bone trades on the NASDAQ stock market under the symbol SIBN.

As of May 10, 2024, SIBN stock price declined to $15.33 with 416,392 million shares trading.

SIBN has a beta of 0.67, meaning it tends to be less sensitive to market movements. SIBN has a correlation of 0.03 to the broad based SPY ETF.

SIBN has a market cap of $631.66 million. This is considered a Small Cap stock.

Last quarter Si-Bone reported $38 million in Revenue and -$.27 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.04.

In the last 3 years, SIBN stock traded as high as $34.38 and as low as $11.14.

The top ETF exchange traded funds that SIBN belongs to (by Net Assets): RAYE, VTI, IWM, VXF, IWO.

SIBN has underperformed the market in the last year with a return of -33.1%, while the SPY ETF gained +27.8%. In the last 3 month period, SIBN fell short of the market, returning -27.1%, while SPY returned +4.2%. However, in the most recent 2 weeks SIBN has outperformed the stock market by returning +5.2%, while SPY returned +2.5%.

SIBN support price is $15.07 and resistance is $16.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SIBN stock will trade within this expected range on the day.